Financial giants have made a conspicuous bullish move on CVS Health. Our analysis of options history for CVS Health (NYSE:CVS) revealed 28 unusual trades.
Delving into the details, we found 42% of traders were bullish, while 39% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $260,007, and 21 were calls, valued at $948,483.
Projected Price Targets
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $75.0 for CVS Health over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for CVS Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CVS Health's whale activity within a strike price range from $40.0 to $75.0 in the last 30 days.
CVS Health 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
About CVS Health
Current Position of CVS Health
- With a volume of 20,524,948, the price of CVS is up 15.18% at $63.35.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 0 days.
Professional Analyst Ratings for CVS Health
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $65.0.
Unusual Options Activity Detected: Smart Money on the Move
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CVS Health, Benzinga Pro gives you real-time options trades alerts.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
